Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT00401232
First received: November 17, 2006
Last updated: September 10, 2014
Last verified: September 2014

November 17, 2006
September 10, 2014
August 2006
December 2015   (final data collection date for primary outcome measure)
"No outcome measures". Blood collected for assay development. [ Time Frame: 1 hour ] [ Designated as safety issue: No ]
To evaluate whether blood sera is suitable for assay development
Complete list of historical versions of study NCT00401232 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development
Blood Collection in Healthy Adult Volunteers to Obtain Serum for Use in Serum Bactericidal Activity Assay Development

This is a study to collect blood from volunteers to assist in assay development.

Not Provided
Interventional
Phase 0
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Healthy Subjects
Procedure: Blood Collection
Blood Collection
Arm 1
Intervention: Procedure: Blood Collection
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
900
December 2015
December 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy Volunteers aged 18-64

Exclusion Criteria:

  • Bleeding disorder
Both
18 Years to 64 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00401232
6108A1-800, B1971032
No
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
September 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP